Literature DB >> 25378704

Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation.

Hua Gao1, Goutam Chakraborty2, Ai Ping Lee-Lim2, Konstantinos J Mavrakis3, Hans-Guido Wendel3, Filippo G Giancotti4.   

Abstract

We have developed a screening platform for the isolation of genetic entities involved in metastatic reactivation. Retroviral libraries of cDNAs from fully metastatic breast-cancer cells or pooled microRNAs were transduced into breast-cancer cells that become dormant upon infiltrating the lung. Upon inoculation in the tail vein of mice, the cells that had acquired the ability to undergo reactivation generated metastatic lesions. Integrated retroviral vectors were recovered from these lesions, sequenced, and subjected to a second round of validation. By using this strategy, we isolated canonical genes and microRNAs that mediate metastatic reactivation in the lung. To identify genes that oppose reactivation, we screened an expression library encoding shRNAs, and we identified target genes that encode potential enforcers of dormancy. Our screening strategy enables the identification and rapid biological validation of single genetic entities that are necessary to maintain dormancy or to induce reactivation. This technology should facilitate the elucidation of the molecular underpinnings of these processes.

Entities:  

Keywords:  cDNA library screen; forward genetic screens; metastatic reactivation; microRNA library screen; shRNA library screen

Mesh:

Substances:

Year:  2014        PMID: 25378704      PMCID: PMC4246349          DOI: 10.1073/pnas.1403234111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Modeling metastasis in the mouse.

Authors:  Paula D Bos; Don X Nguyen; Joan Massagué
Journal:  Curr Opin Pharmacol       Date:  2010-07-01       Impact factor: 5.547

2.  MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.

Authors:  Kim J Png; Mitsukuni Yoshida; Xiang H-F Zhang; Weiping Shu; Hyeseung Lee; Andreas Rimner; Timothy A Chan; Elizabeth Comen; Viktor P Andrade; Seok Won Kim; Tari A King; Clifford A Hudis; Larry Norton; James Hicks; Joan Massagué; Sohail F Tavazoie
Journal:  Genes Dev       Date:  2011-02-01       Impact factor: 11.361

3.  Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs.

Authors:  Thordur Oskarsson; Swarnali Acharyya; Xiang H-F Zhang; Sakari Vanharanta; Sohail F Tavazoie; Patrick G Morris; Robert J Downey; Katia Manova-Todorova; Edi Brogi; Joan Massagué
Journal:  Nat Med       Date:  2011-06-26       Impact factor: 53.440

Review 4.  Non-germline genetically engineered mouse models for translational cancer research.

Authors:  Joerg Heyer; Lawrence N Kwong; Scott W Lowe; Lynda Chin
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

5.  Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.

Authors:  Cheol Hwangbo; Jaekyung Kim; Jung Joon Lee; Jeong-Hyung Lee
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

Review 6.  NUMB-ing down cancer by more than just a NOTCH.

Authors:  Salvatore Pece; Stefano Confalonieri; Pascale R Romano; Pier Paolo Di Fiore
Journal:  Biochim Biophys Acta       Date:  2010-10-16

7.  The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation.

Authors:  Vidisha Tripathi; Jonathan D Ellis; Zhen Shen; David Y Song; Qun Pan; Andrew T Watt; Susan M Freier; C Frank Bennett; Alok Sharma; Paula A Bubulya; Benjamin J Blencowe; Supriya G Prasanth; Kannanganattu V Prasanth
Journal:  Mol Cell       Date:  2010-09-24       Impact factor: 17.970

8.  Diverse pathways generate microRNA-like RNAs and Dicer-independent small interfering RNAs in fungi.

Authors:  Heng-Chi Lee; Liande Li; Weifeng Gu; Zhihong Xue; Susan K Crosthwaite; Alexander Pertsemlidis; Zachary A Lewis; Michael Freitag; Eric U Selker; Craig C Mello; Yi Liu
Journal:  Mol Cell       Date:  2010-04-22       Impact factor: 17.970

9.  Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.

Authors:  H Boukerche; H Aissaoui; C Prévost; H Hirbec; S K Das; Z-Z Su; D Sarkar; P B Fisher
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

10.  In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression.

Authors:  Corbin E Meacham; Emily E Ho; Esther Dubrovsky; Frank B Gertler; Michael T Hemann
Journal:  Nat Genet       Date:  2009-09-27       Impact factor: 38.330

View more
  15 in total

Review 1.  In vivo functional screening for systems-level integrative cancer genomics.

Authors:  Julia Weber; Christian J Braun; Dieter Saur; Roland Rad
Journal:  Nat Rev Cancer       Date:  2020-07-07       Impact factor: 60.716

Review 2.  The biology and clinical implications of prostate cancer dormancy and metastasis.

Authors:  Colm Morrissey; Robert L Vessella; Paul H Lange; Hung-Ming Lam
Journal:  J Mol Med (Berl)       Date:  2015-10-21       Impact factor: 4.599

3.  Identification of Genes Regulating Breast Cancer Dormancy in 3D Bone Endosteal Niche Cultures.

Authors:  Julie McGrath; Louis Panzica; Ryan Ransom; Henry G Withers; Irwin H Gelman
Journal:  Mol Cancer Res       Date:  2019-01-16       Impact factor: 5.852

4.  Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling.

Authors:  Hua Gao; Goutam Chakraborty; Zhanguo Zhang; Intissar Akalay; Mayur Gadiya; Yaquan Gao; Surajit Sinha; Jian Hu; Cizhong Jiang; Muzaffar Akram; Edi Brogi; Birgit Leitinger; Filippo G Giancotti
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

5.  MALAT1 long non-coding RNA and breast cancer.

Authors:  Gayatri Arun; David L Spector
Journal:  RNA Biol       Date:  2019-03-22       Impact factor: 4.766

Review 6.  EMT, CTCs and CSCs in tumor relapse and drug-resistance.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Oncotarget       Date:  2015-05-10

Review 7.  Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

Authors:  Dhiraj Kumar; Mahadeo Gorain; Gautam Kundu; Gopal C Kundu
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

8.  Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.

Authors:  Nai-Si Huang; Ya-Yun Chi; Jing-Yan Xue; Meng-Ying Liu; Sheng Huang; Miao Mo; Shu-Ling Zhou; Jiong Wu
Journal:  Oncotarget       Date:  2016-06-21

9.  Smyd5 plays pivotal roles in both primitive and definitive hematopoiesis during zebrafish embryogenesis.

Authors:  Tomoaki Fujii; Shin-Ichiro Tsunesumi; Hiroshi Sagara; Miyo Munakata; Yoshihiro Hisaki; Takao Sekiya; Yoichi Furukawa; Kazuhiro Sakamoto; Sumiko Watanabe
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

10.  Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.

Authors:  Linda Xiaoyan Li; Julie Xia Zhou; James P Calvet; Andrew K Godwin; Roy A Jensen; Xiaogang Li
Journal:  Cell Death Dis       Date:  2018-02-27       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.